GB0329884D0 — Method
Assigned to Glaxo Group Ltd · Expires 2004-01-28 · 22y expired
What this patent protects
There is provided a method for predicting the tendency of inhaled particles to deposit within a first patient's throat when said particles are inhaled through an airway defined by said throat. The method comprises determining at least one internal physical parameter of said airwa…
USPTO Abstract
There is provided a method for predicting the tendency of inhaled particles to deposit within a first patient's throat when said particles are inhaled through an airway defined by said throat. The method comprises determining at least one internal physical parameter of said airway defined by the first throat by means of acoustic imaging of the airway defined by the first throat, and matching said at least one internal physical parameter of the airway of the first throat with a dataset comprising pre-determined data relating to the corresponding internal physical parameter for the throat of at least one other patient, wherein said dataset also comprises pre-determined data relating to the tendency of said inhaled particles to deposit within said plural at least one other patient's throat, and said matching thereby enables prediction of the tendency for the inhaled particles to deposit within the first patient's throat.
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.